Edition:
United Kingdom

Divi's Laboratories Ltd (DIVI.NS)

DIVI.NS on National Stock Exchange of India

1,724.35INR
18 Apr 2019
Change (% chg)

Rs9.75 (+0.57%)
Prev Close
Rs1,714.60
Open
Rs1,716.00
Day's High
Rs1,731.75
Day's Low
Rs1,713.00
Volume
334,997
Avg. Vol
643,031
52-wk High
Rs1,774.95
52-wk Low
Rs994.95

Latest Key Developments (Source: Significant Developments)

India's Divi's Laboratories Says No Irregularities Found Post Income Tax Search Operation
Tuesday, 19 Feb 2019 

Feb 19 (Reuters) - Divi's Laboratories Ltd ::SAYS TAX OFFICIALS CONDUCTED SEARCH AT CO'S HEAD OFFICE, RESEARCH CENTRE, MANUFACTURING SITES FROM FEB 14 TO 18.SAYS NO IRREGULARITIES HAVE BEEN FOUND POST SEARCH OPERATION.  Full Article

Divi's Laboratories says US FDA's import alert on unit II at Vishakhapatnam removed‍​
Wednesday, 15 Nov 2017 

Nov 15 (Reuters) - Divi's Laboratories Ltd ::Says US FDA's import alert 66-40 on co's unit II at Vishakhapatnam has been removed‍​.  Full Article

Divi's Laboratories USFDA completed evaluation of co's corrective actions in response to warning letter
Friday, 10 Nov 2017 

Nov 10 (Reuters) - Divi's Laboratories Ltd :Informed that USFDA completed evaluation of co's corrective actions in response to FDA's warning letter dated April 13.  Full Article

Divi's Labs says U.S.FDA to lift import alert on co's unit-II at Visakhapatnam​
Thursday, 2 Nov 2017 

Nov 2 (Reuters) - Divi's Laboratories Ltd ::U.S.FDA to lift import alert 66-40 and move to close out warning letter issued to co's unit-II at Visakhapatnam​.  Full Article

India's Divi's Laboratories Sept-qtr profit falls
Tuesday, 31 Oct 2017 

Oct 31 (Reuters) - Divi's Laboratories Ltd :Sept quarter net profit 2.07 billion rupees versus profit of 2.24 billion rupees year ago.Sept quarter revenue from operations 8.90 billion rupees versus 10.05 billion rupees year ago.Says revenue during current half of year has been impacted due to‍​ FDA import alert, export shipments delay.  Full Article

Divi's Laboratories gets form 483 with 6 observations at unit-2 on USFDA inspection
Wednesday, 20 Sep 2017 

Sept 20 (Reuters) - Divi's Laboratories Ltd ::Says Divi's Laboratories Limited, unit-2 has been inspected by US-FDA from September 11 to September 19, 2017.Inspection was for full CGMP and verification of all corrective actions proposed against previous inspection observations.On completion of inspection, co got form 483 citing 6 observations which are procedural.  Full Article

Divi's Laboratories says U.S. FDA will lift import alert 99-32 imposed on unit-II at Visakhapatnam
Monday, 10 Jul 2017 

July 10 (Reuters) - Divi's Laboratories Ltd :Says informed by US-FDA that it will lift import alert 99-32 imposed on company's unit-II at Visakhapatnam.Says has filed a detailed responses and given updates to form-483 and warning letter within stipulated time.Says has taken up appropriate remediation measures to address concerns raised by US-FDA.Says company awaits further action from US-FDA.  Full Article

India's Divi's Labs March-qtr profit falls
Friday, 26 May 2017 

May 26 (Reuters) - India's Divi's Laboratories Ltd :March quarter net profit 2.59 billion rupees versus profit3.22 billion rupees year ago.March quarter total revenue from operations 10.88 billion rupees versus 11.21 billion rupees year ago.Recommended dividend of 10 rupees per share.Says got warning letter from FDA for unit -II at vishakapatnam.Says co repsonded to observations in form 483.  Full Article